ART BioScience
PrivateLast Round
Series B
Jul 29, 2025
Total Funding Raised
$245M
Company Overview
ART BioScience is a biotechnology company that develops mRNA-based therapeutics and gene-editing therapies for the treatment of Duchenne muscular dystrophy and other rare genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ART BioScience Comparables
Compare ART BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spot Biosystems | 82% | |
| Entrada Therapeutics | 70% | |
| Solid Biosciences Inc. | 70% | |
ART BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2025 | ||||
| Series A | Dec 7, 2023 | ||||
| Seed | Jun 1, 2023 |
ART BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series A, Series B, Seed |
| B Capital Group | Series B |
| Alexandria Venture Investments | Series B |
| F-Prime Capital | Series A, Series B, Seed |
| Sofinnova Investments | Series B |
| Qatar Investment Authority | Series B |
| Third Rock Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2025
$132M round led by B Capital Group and Sofinnova Investments.
- Dec 7, 2023
$90M round led by Third Rock Ventures
ART BioScience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ART BioScience's valuation, stock price, and market status.